首页> 外文期刊>Iranian Journal of Pathology >Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience
【24h】

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience

机译:败血症患儿血浆纤维蛋白原和D-二聚体:单中心经验

获取原文
       

摘要

Background & Objectives: In sepsis, enhanced fibrin formation, impaired fibrin degradation, and intravascular fibrin deposition lead to a prothrombotic state. The current study aimed at measuring various coagulation parameters to predict an early marker for disseminated intravascular coagulation (DIC). Methods: ?The current prospective study was conducted from January 2012 to April 2013 on 50 children aged 1-10 years with clinically suspected sepsis referred to the Department of Pediatrics of a tertiary care center in New Delhi, India. Patients were evaluated in accordance with criteria for acute infection (i e, symptoms less than seven days) confirmed in all patients in the laboratory. Patients receiving antibiotics 24-48 hours preceding the admission were excluded from study. Prothrombin time, activated partial thromboplastin time, plasma fibrinogen, and D-dimer were measured at the time of admission in 50 patients and 50 controls. Results: D-dimer was positive in 36 (72%) patients and negative in all controls. The difference was statistically significant (P P P Conclusion: ?Though none of the current study patients developed overt disseminated intravascular coagulation, the high positivity for D-dimer suggested that it should be measured in children with sepsis for early identification of DIC. This can aid better management as additional coagulation based therapy such as recombinant anti-thrombin and thrombomodulin may help to improve prognosis.
机译:背景与目的:在脓毒症中,血纤蛋白形成增加,血纤蛋白降解受损和血管内血纤蛋白沉积导致血栓形成前状态。当前的研究旨在测量各种凝血参数,以预测弥散性血管内凝血(DIC)的早期标记。方法:?当前的前瞻性研究于2012年1月至2013年4月在印度新德里三级护理中心儿科处对50名1-10岁的临床怀疑脓毒症儿童进行。根据实验室中所有患者确诊的急性感染标准(即症状少于7天)对患者进行评估。入院前24-48小时接受抗生素治疗的患者被排除在研究范围之外。在入院时测量了50名患者和50名对照的凝血酶原时间,活化的部分凝血活酶时间,血浆纤维蛋白原和D-二聚体。结果:D-二聚体在36例患者中阳性(72%),在所有对照中均为阴性。差异具有统计学意义(PPP结论:尽管目前研究的患者均未出现明显的弥散性血管内凝血,但D-二聚体的阳性率较高,因此建议对败血症患儿进行D-二聚体测定,以尽早发现DIC。作为其他基于凝血的疗法(例如重组抗凝血酶和血栓调节蛋白)的管理可能有助于改善预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号